Chunyan Sun

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
Chunyan Sun, Chun-yan Sun, Chun‐yan Sun
Publication record
117 papers · 2,318 citations · H-index 26

PAPERS

P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T(4;14)-POSITIVE MULTIPLE MYELOMA
20230 citationsauthor #9
LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment
202323 citationsauthor #7
The predictive value of MiR-221 in cancer chemoresistance: a systematic review and meta-analysis
20231 citationsauthor #8
MALAT1 regulates network of microRNA-15a/16-VEGFA to promote tumorigenesis and angiogenesis in multiple myeloma.
202313 citationsauthor #9
ACSL4: a Double-edged Sword Target in Multiple Myeloma, Promotes Cell Proliferation and Sensitizes Cell to Ferroptosis.
202329 citationsauthor #10
Sequence Variation of Candida albicans Sap2 Enhances Fungal Pathogenicity via Complement Evasion and Macrophage M2‐Like Phenotype Induction
202320 citationsauthor #9
CCL18 promotes migration and invasion of multiple myeloma cells and is associated with poor prognosis.
20226 citationsauthor #9
TEMPI Syndrome: Update on Clinical Features, Management, and Pathogenesis
202210 citationsauthor #7
Looking into Endoplasmic Reticulum Stress: The Key to Drug-Resistance of Multiple Myeloma?
202215 citationsauthor #3
Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis
202226 citationsauthor #7
Preliminary Results from the Launch Study-a Multicenter, Open-Label Study of Selinexor, Dexamethasone and Chemotherapy Drugs in Relapsed/ Refractory Multiple Myeloma
20222 citationsauthor #1
siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells
20222 citationsauthor #1
A prognostication system based on clinical parameters and [^18F]-FDG PET/CT in patients with newly diagnosed multiple myeloma
20228 citationsauthor #8
Cardiovascular-specific mortality among multiple myeloma patients: a population-based study
202221 citationsauthor #5
Ferroptosis in hematological malignancies and its potential network with abnormal tumor metabolism.
202232 citationsauthor #6
siRNA-mediated inhibition of endogenous brain-derived neurotrophic factor gene modulates the biological behavior of HeLa cells
20210 citationsauthor #1
JunB is a key regulator of multiple myeloma bone marrow angiogenesis
202138 citationsauthor #12
Corrigendum: Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study
20211 citationsauthor #7
Clinical Value of ctDNA in Hematological Malignancies (Lymphomas, Multiple Myeloma, Myelodysplastic Syndrome, and Leukemia): A Meta-Analysis
202110 citationsauthor #5
Doxycycline Combined With Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Cardiac Light-Chain Amyloidosis: A Multicenter Randomized Controlled Trial
202130 citationsauthor #8
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis
20210 citationsauthor #12
Treatment and outcome patterns of patients with Waldenström’s macroglobulinemia: a large, multicenter retrospective review in China
202110 citationsauthor #7
Whole-genome sequencing suggests a role of MIF in the pathophysiology of TEMPI syndrome.
202111 citationsauthor #1
International Prognostic Index-Based Immune Prognostic Model for Diffuse Large B-Cell Lymphoma
202114 citationsauthor #6
Circulating Plasma Cells as a Biomarker to Predict Newly Diagnosed Multiple Myeloma Prognosis: Developing Nomogram Prognostic Models
202117 citationsauthor #6
Prognostic nomogram incorporating cytokines for overall survival in patients with newly diagnosed multiple myeloma.
20219 citationsauthor #8
Nanoparticles Dual Targeting Both Myeloma Cells and Cancer-Associated Fibroblasts Simultaneously to Improve Multiple Myeloma Treatment
202114 citationsauthor #3
FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m6A-YTHDF2-dependent manner.
202161 citationsauthor #17
Comprehensive geriatric assessment in newly diagnosed older myeloma patients: a multicentre, prospective, non-interventional study.
202114 citationsauthor #11
The relationship among primary anatomic subsite and risk and distribution of second malignant neoplasms in patients with stage I/II diffuse large B-cell lymphoma: An analysis of the surveillance, epidemiology, and end results database
20217 citationsauthor #9
A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myeloma
2021173 citationsauthor #19
An IPI based immune prognostic model for diffuse large B-cell lymphoma
20210 citationsauthor #6
Identification of distinctive long noncoding RNA competitive interactions and a six‐methylated‐gene prognostic signature in acute myeloid leukemia with −5/del(5q) or −7/del(7q)
20204 citationsauthor #6
The Role of Noncoding RNAs in B-Cell Lymphoma
202011 citationsauthor #4
COVID-19 in patients with multiple myeloma: a cross-sectional survey from the most severely affected region in China
20201 citationsauthor #1
Waldenström's Macroglobulinaemia in the Modern Era: Real World Outcomes and Prognostication across 35 Chinese Academic Hospitals
20200 citationsauthor #7
Trends in Incidence and Mortality of Waldenström Macroglobulinemia: A Population-Based Study
202016 citationsauthor #7
Roles of noncoding RNAs in drug resistance in multiple myeloma
20206 citationsauthor #4
Disturbed MAPK pathway in early bilateral testicular extramedullary relapse of multiple myeloma.
20204 citationsauthor #13
A Novel Scoring System for Risk Assessment of Elderly Patients With Cytogenetically Normal Acute Myeloid Leukemia Based on Expression of Three AQP1 DNA Methylation-Associated Genes
20207 citationsauthor #9
Fto Promotes Extramedullary Progression of Multiple Myeloma By Regulation of HSF1 through m6a RNA Methylation
20193 citationsauthor #12
Clinical characteristics and prognosis of immunoglobulin D myeloma in the novel agent era
201917 citationsauthor #6
Doxycycline Combined with Bortezomib-Cyclophosphamide-Dexamethasone Chemotherapy for Newly Diagnosed Patients with Mayo 2004 Stage II-III Light-Chain Amyloidosis: A Randomized Controlled Multicenter Study
20193 citationsauthor #8
Multiple Myeloma Pathogenesis: The Role of Junb in Bone Marrow Angiogenesis
20191 citationsauthor #14
Comprehensive Geriatric Assessment in Consecutive Newly-Diagnosed Elderly Multiple Myeloma Patients in China: A Multicentered, Prospective, Non-Interventional Study
20191 citationsauthor #11
抗CD38抗体Daratumumab治疗复发/难治性原发性轻链型淀粉样变二例报告并文献复习
20190 citationsauthor #7
Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database
201933 citationsauthor #7
Bortezomib-Based Chemotherapy with Autologous Stem Cell Transplantation for Monoclonal Gammopathy of Renal Significance: A Case Report and Literature Review
20195 citationsauthor #2
Myeloid-derived suppressor cells endow stem-like qualities to multiple myeloma cells by inducing piRNA-823 expression and DNMT3B activation
2019134 citationsauthor #3
miR-221/222-Mediated Inhibition of Autophagy Promotes Dexamethasone Resistance in Multiple Myeloma.
201954 citationsauthor #13
Prognostic role of neutrophil–lymphocyte ratio in multiple myeloma: a dose–response meta-analysis
201818 citationsauthor #4
Prognostic role of neutrophil-to-lymphocyte ratio in diffuse large B cell lymphoma patients: an updated dose–response meta-analysis
201849 citationsauthor #5
Identification of long non-coding RNA competing interactions and biological pathways associated with prognosis in pediatric and adolescent cytogenetically normal acute myeloid leukemia
201820 citationsauthor #5
MiR-221/222 Promote Dexamethasone Resistance of Multiple Myeloma through Inhibition of Autophagy By Targeting ATG12
20180 citationsauthor #7
MicroRNA‐324‐5p regulates stemness, pathogenesis and sensitivity to bortezomib in multiple myeloma cells by targeting hedgehog signaling
201870 citationsauthor #12
Prognostic and clinicopathological significance of long noncoding RNA HOXA11-AS expression in human solid tumors: a meta-analysis
201839 citationsauthor #4
MicroRNA-324-5p suppresses the migration and invasion of MM cells by inhibiting the SCFβ-TrCP E3 ligase.
20189 citationsauthor #10
Allogeneic stem-cell transplantation for multiple myeloma: a systematic review and meta-analysis from 2007 to 2017
201832 citationsauthor #5
siRNA-mediated inhibition of endogenous brain‑derived neurotrophic factor gene modulates the biological behavior of HeLa cells.
20172 citationsauthor #1
Efficacy and safety of bortezomib maintenance in patients with newly diagnosed multiple myeloma: a meta-analysis
201727 citationsauthor #1
Research advance in role of bone marrow microenvironment on pathogenesis of multiple myeloma
20170 citationsauthor #2
Minimal residual disease detection in multiple myeloma: current status, challenges and strategies
20170 citationsauthor #1
The AP-1 transcription factor JunB is essential for multiple myeloma cell proliferation and drug resistance in the bone marrow microenvironment
201775 citationsauthor #12
Efficacy and Safety of Panobinostat in Relapsed or/and Refractory Multiple Myeloma: Meta Analyses of Clinical Trials and Systematic Review
201611 citationsauthor #2
[Expression of autophagy related gene BECLIN-1 and number of autophagic vacuoles in bone marrow mononuclear cells from 40 myelodysplastic syndromes patients and their significance].
20154 citationsauthor #5
脑源性神经营养因子基因沉默对RPMI8226细胞表达VEGF的影响
20150 citationsauthor #7
Genetic analysis should be included in clinical practice when screening for antithrombin deficiency
201428 citationsauthor #15
piRNA-823 contributes to tumorigenesis by regulating de novo DNA methylation and angiogenesis in multiple myeloma
2014219 citationsauthor #3
Role of brain-derived neurotrophic factor in bone marrow angiogenesis in multiple myeloma
20135 citationsauthor #2
Gene silencing of the BDNF/TrkB axis in multiple myeloma blocks bone destruction and tumor burden in vitro and in vivo
201321 citationsauthor #2
miR-15a and miR-16 affect the angiogenesis of multiple myeloma by targeting VEGF.
2013221 citationsauthor #1
Brain‐derived neurotrophic factor is a potential osteoclast stimulating factor in multiple myeloma
201236 citationsauthor #1
Brain-Derived Neurotrophic Factor Enhances Osteoclastogenesis in Multiple Myeloma via Upregulation of RANKL/OPG Ratio Both in Vitro and in a Murine Model of Myeloma Bone Disease
20120 citationsauthor #2
Inhibition of BDNF in Multiple Myeloma Blocks Osteoclastogenesis via Down-Regulated Stroma-Derived RANKL Expression Both In Vitro and In Vivo
201237 citationsauthor #2
Cardamonin exerts potent activity against multiple myeloma through blockade of NF-κB pathway in vitro.
201253 citationsauthor #2
Clinical significance of chromosomal abnormalities detected by interphase fluorescence in situ hybridization in newly diagnosed multiple myeloma patients.
201113 citationsauthor #3
Once Weekly Bortezomib Plus Dexamethasone in Newly Diagnosed Multiple Myeloma: A Preliminary Study in Chinese Patients
20111 citationsauthor #7
Brain-derived neurotrophic factor induces proliferation, migration, and VEGF secretion in human multiple myeloma cells via activation of MEK-ERK and PI3K/AKT signaling
201035 citationsauthor #1
Brain-Derived Neurotrophic Factor Is a Potential Osteoclast Stimulatory Factor In Multiple Myeloma
20101 citationsauthor #1
Cardamonin, a Novel Blocker of STAT3 and Nuclear Factor-κB Activation, Suppresses Proliferation, Arrests Cell Cycle, and Potentiates Apoptosis In Human Multiple Myeloma Cells
20101 citationsauthor #2
MiR-15a and Mir-16-1 Affects the Angiogenesis of Multiple Myeloma by Targeting VEGF-A
20100 citationsauthor #1
Lentiviral shRNA silencing of BDNF inhibits in vivo multiple myeloma growth and angiogenesis via down‐regulated stroma‐derived VEGF expression in the bone marrow milieu
201025 citationsauthor #3
Silencing of BDNF Expression by shRNA Down-Regulates Stroma-Derived VEGF Secretion and Inhibits In Vivo Multiple Myeloma Growth and Angiogenesis in the Bone Marrow Milieu.
20090 citationsauthor #3
The effect of brain-derived neurotrophic factor on angiogenesis
20097 citationsauthor #1
[Effect of RNA interference targeting brain-derived neurotrophic factor gene on HeLa cell proliferation and apoptosis].
20091 citationsauthor #2
Successful treatment of myeloid neoplasms associated with PDGFRA rearrangement with imatinib mesylate
20091 citationsauthor #1
[Study of brain-derived neurotrophic factor activating TrkB signaling cascades in the pathogenesis of multiple myeloma].
20080 citationsauthor #1
[Brain-derived neurotrophic factor promotes the secretion of MMP-9 in human myeloma cell through modulation of nucleus factor-kappaB].
20085 citationsauthor #3
Brain-Derived Neurotrophic Factor Induces Proliferation, Migration and VEGF Secretion in Human Multiple Myeloma Cells Via Activation of MEK-ERK and PI3K/Akt Signaling.
20080 citationsauthor #2
[Role of multiple myeloma cells on normal endothelial cells in co-culture system].
20082 citationsauthor #3
Brain derived neurotrophic factor induces endothelial cells angiogenesis through AKT and ERK1/2 signal pathway.
200811 citationsauthor #4
Antitumor effect of anti-brain derived neurotrophic factor monoclonal antibody in human multiple myeloma xenograft animal model.
20081 citationsauthor #5
[Effect of MAPK signaling pathway phosphorylation on proliferation of myeloma cell line KM3 by insulin-like growth factor 1].
20070 citationsauthor #3
[Human multiple myeloma cells stimulate differentiation of endothelial cells to form capillary-like networks in two different co-culture systems].
20070 citationsauthor #3
Antimyeloma effects of resveratrol through inhibition of angiogenesis.
200744 citationsauthor #2
[Human multiple myeloma cell line RPMI8226 activates brain derived neurotrophic factor autocrine loop of co-cultured endothelial cells].
20070 citationsauthor #3
Identification of brain-derived neurotrophic factor as a novel angiogenic protein in multiple myeloma.
200742 citationsauthor #5
[Establishment of multiple myeloma mouse models expressing brain derived neurotrophic factor].
20070 citationsauthor #5
[Study of molecular mechanism of doxorubicin enhancement of TRAIL, inducing apoptosis of myeloma cell line KM3].
20070 citationsauthor #3
[Monoclonal antibody against brain derived neurotrophic factor inhibits myeloma growth and angiogenesis in the xenograft NOD/SCID animal model].
20071 citationsauthor #5

TIMELINE

2004 5 citations

2005 7 citations

2006 222 citations

2007 87 citations

2008 19 citations

2009 9 citations

2010 62 citations

2011 14 citations

2012 126 citations

2013 247 citations

2014 247 citations

2015 4 citations

2016 11 citations

2017 104 citations

2018 237 citations

2019 251 citations

2020 49 citations

2021 409 citations

2022 122 citations

2023 86 citations

Unknown 2 citations

Chunyan Sun

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT